Taylor Morrison Home Statistics
Total Valuation
TMHC has a market cap or net worth of $6.12 billion. The enterprise value is $7.73 billion.
| Market Cap | 6.12B |
| Enterprise Value | 7.73B |
Important Dates
The next estimated earnings date is Wednesday, July 24, 2024, before market open.
| Earnings Date | Jul 24, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TMHC has 105.76 million shares outstanding. The number of shares has decreased by -1.73% in one year.
| Shares Outstanding | 105.76M |
| Shares Change (YoY) | -1.73% |
| Shares Change (QoQ) | -0.95% |
| Owned by Insiders (%) | 2.82% |
| Owned by Institutions (%) | 100.76% |
| Float | 102.84M |
Valuation Ratios
The trailing PE ratio is 8.27 and the forward PE ratio is 7.22. TMHC's PEG ratio is 1.51.
| PE Ratio | 8.27 |
| Forward PE | 7.22 |
| PS Ratio | 0.82 |
| Forward PS | 0.80 |
| PB Ratio | 1.13 |
| P/FCF Ratio | 20.44 |
| PEG Ratio | 1.51 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 7.42, with an EV/FCF ratio of 25.84.
| EV / Earnings | 10.07 |
| EV / Sales | 1.04 |
| EV / EBITDA | 7.42 |
| EV / EBIT | 7.69 |
| EV / FCF | 25.84 |
Financial Position
| Current Ratio | n/a |
| Quick Ratio | n/a |
| Debt / Equity | 0.40 |
| Debt / EBITDA | 2.09 |
| Debt / FCF | 7.27 |
| Interest Coverage | -87.68 |
Financial Efficiency
Return on equity (ROE) is 14.60% and return on invested capital (ROIC) is 9.97%.
| Return on Equity (ROE) | 14.60% |
| Return on Assets (ROA) | 8.80% |
| Return on Capital (ROIC) | 9.97% |
| Revenue Per Employee | $2.66M |
| Profits Per Employee | $274,339 |
| Employee Count | 2,800 |
| Asset Turnover | 0.86 |
| Inventory Turnover | 1.00 |
Taxes
In the past 12 months, TMHC has paid $248.63 million in taxes.
| Income Tax | 248.63M |
| Effective Tax Rate | 24.45% |
Stock Price Statistics
The stock price has increased by +36.30% in the last 52 weeks. The beta is 1.88, so TMHC's price volatility has been higher than the market average.
| Beta (1Y) | 1.88 |
| 52-Week Price Change | +36.30% |
| 50-Day Moving Average | 58.07 |
| 200-Day Moving Average | 50.81 |
| Relative Strength Index (RSI) | 49.34 |
| Average Volume (30 Days) | 713,407 |
Short Selling Information
The latest short interest is 2.26 million, so 2.14% of the outstanding shares have been sold short.
| Short Interest | 2.26M |
| Short Previous Month | 2.66M |
| Short % of Shares Out | 2.14% |
| Short % of Float | 2.20% |
| Short Ratio (days to cover) | 3.16 |
Income Statement
In the last 12 months, TMHC had revenue of $7.46 billion and earned $768.15 million in profits. Earnings per share was $6.99.
| Revenue | 7.46B |
| Gross Profit | 1.80B |
| Operating Income | 1.00B |
| Pretax Income | 1.02B |
| Net Income | 768.15M |
| EBITDA | 1.04B |
| EBIT | 1.01B |
| Earnings Per Share (EPS) | $6.99 |
Balance Sheet
The company has $557.39 million in cash and $2.17 billion in debt, giving a net cash position of -$1.62 billion or -$15.29 per share.
| Cash & Cash Equivalents | 557.39M |
| Total Debt | 2.17B |
| Net Cash | -1.62B |
| Net Cash Per Share | -$15.29 |
| Equity / Book Value | 5.43B |
| Book Value Per Share | 51.30 |
| Working Capital | n/a |
Cash Flow
In the last 12 months, operating cash flow was $327.98 million and capital expenditures -$28.73 million, giving a free cash flow of $299.25 million.
| Operating Cash Flow | 327.98M |
| Capital Expenditures | -28.73M |
| Free Cash Flow | 299.25M |
| FCF Per Share | $2.81 |
Margins
Gross margin is 24.15%, with operating and profit margins of 13.45% and 10.30%.
| Gross Margin | 24.15% |
| Operating Margin | 13.45% |
| Pretax Margin | 13.64% |
| Profit Margin | 10.30% |
| EBITDA Margin | 13.97% |
| EBIT Margin | 13.48% |
| FCF Margin | 4.01% |
Dividends & Yields
TMHC does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 1.73% |
| Shareholder Yield | 1.73% |
| Earnings Yield | 12.56% |
| FCF Yield | 4.89% |
Analyst Forecast
The average price target for TMHC is $59.40, which is 2.72% higher than the current price. The consensus rating is "Buy".
| Price Target | $59.40 |
| Price Target Difference | 2.72% |
| Analyst Consensus | Buy |
| Analyst Count | 7 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 4 |